We are live on
!
Find out more
HVC
Healthcare Value Capital Portfolio holdings
AUM
$50.7M
1-Year Est. Return
24.72%
This Fund
S&P 500
This Quarter
Est. Return
-12.99%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$59.5M
AUM Growth
+$25.5M
(+75%)
Cap. Flow
+$23.8M
Cap. Flow
% of AUM
39.98%
Top 10 Holdings %
Top 10 Hldgs %
59.39%
Holding
29
New
13
Increased
5
Reduced
2
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$4.19M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$3.88M |
| 3 |
YARW
Yarrow Bioscience
YARW
|
+$3.7M |
| 4 |
AstraZeneca
AZN
|
+$3.53M |
| 5 |
ProShares UltraPro Short S&P 500
SPXU
|
+$3.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$1.67M |
| 2 |
Viking Therapeutics
VKTX
|
+$1.54M |
| 3 |
Gilead Sciences
GILD
|
+$1.38M |
| 4 |
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
|
+$1.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 72.72% |
| 2 | Miscellaneous | 26.63% |
| 3 | Consumer Staples | 0.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Greenlane Holdings
GNLN
$1.92M
| – | – |
0
| – | – |
|
|
27
Viking Therapeutics
VKTX
$3.95B
| – | – |
-250,000
| Closed | -$1.54M |
|
|
FOMX
28
CALL
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| – | – |
-50,000
| Closed | -$167K |
|
|
FOMX
29
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| – | – |
-350,000
| Closed | -$1.17M |
|
Similar funds
C
CC
FCOI
FCOI
BI
KC
SCIM
MCP
Healthcare Value Capital's Q1 2020 Portfolio in Review
As of Q1 2020, Healthcare Value Capital held 29 positions worth $59.5M, up 75% from $34M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Healthcare Value Capital deployed $23.8M of net new capital in Q1 2020, opening 13 new positions and adding to 5 existing holdings. Its largest new stake was Labcorp: 29,100 shares worth $3.16M.
By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 93% a quarter earlier, followed by Miscellaneous and Consumer Staples.
On the sell side, the largest reduction was CVS Health, an estimated $1.67M trimmed.
- Healthcare Value Capital's largest Q1 2020 buy was Labcorp: 29,100 shares worth $3.16M.
- Healthcare Value Capital added most to McKesson in Q1 2020, an estimated $2.2M increase.
- Healthcare Value Capital's biggest Q1 2020 reduction was CVS Health, cutting an estimated $1.67M.
- Healthcare Value Capital fully exited Viking Therapeutics in Q1 2020, selling an estimated $1.54M.
- Healthcare Value Capital's ten largest holdings make up 59% of its $59.5M portfolio in Q1 2020.
- Healthcare Value Capital opened 13 new positions and closed 3 in Q1 2020.
- Healthcare Value Capital's portfolio value rose 75% quarter-over-quarter to $59.5M.
Based on Healthcare Value Capital's 13F filing for Q1 2020, filed 15 May 2020.